Study Reveals Details of Immune Defense Guidance System

At the beginning of an immune response, a molecule known to mobilize immune cells into the bloodstream, where they home in on infection sites, rapidly shifts position, a new study shows. Researchers say this indirectly amplifies the attack on foreign microbes or the body’s own tissues.

Read more

Pre-COVID Subway Air Polluted from DC to Boston, But New York Region’s Is the Worst, Study Finds

New York City’s transit system exposes riders to more inhaled pollutants than any other metropolitan subway system in the Northeastern United States, a new study finds. Yet even its “cleaner” neighbors struggle with enough toxins to give health-conscious travelers pause.

Read more

Schizophrenia Second Only To Age as Greatest Risk Factor for COVID-19 Death

People with schizophrenia, a mental disorder that affects mood and perception of reality, are almost three times more likely to die from the coronavirus than those without the psychiatric illness, a new study shows. Their higher risk, the investigators say, cannot be explained by other factors that often accompany serious mental health disorders, such as higher rates of heart disease, diabetes, and smoking.

Read more

New Study Finds Once Hospitalized, Black Patients with COVID-19 Have Lower Risk of Death than White Patients

A team of investigators at NYU Langone Health has found that once hospitalized, Black patients (after controlling for other serious health conditions and neighborhood income) were less likely to have severe illness, die, or be discharged to hospice compared to White patients.

Read more

New York City’s Coronavirus Outbreak Spread from More European Sources Than First Reported

The COVID-19 pandemic started earlier than previously thought in New York City and Long Island by dozens of people infected mostly with strains from Europe. A new analysis also shows that most of the spread was within the community, as opposed to coming from people who had traveled.

Read more

COVID-19 Frequently Causes Neurological Injuries

Without directly invading the brain or nerves, the virus responsible for COVID-19 causes potentially damaging neurological injuries in about one in seven infected, a new study shows. These injuries range from temporary confusion due to low body-oxygen levels, to stroke and seizures in the most serious cases, say the study authors.

Read more

New Study Finds Racial Disparities in COVID-19-related Deaths Exist Beyond Income Differences in 10 Large U.S. Cities

New analyses by a team of researchers at NYU Grossman School of Medicine examine the interplay between race/ethnicity and income on COVID-19 cases and related deaths in 10 major U.S. cities. The researchers found that non-white counties had higher cumulative incidences and deaths compared to predominantly white counties—and this was true for both low-income and high-income communities.

Read more

As Evidence of “Hormone Disruptor” Chemical Threats Grows, Experts Call for Stricter Regulation

A growing number of chemicals in pesticides, flame retardants, and certain plastics have been linked to widespread health problems including infertility, diabetes, and impaired brain development, a set of reviews of hundreds of studies concludes.

Read more

New COVID Local Risk Index Helps Cities Identify Neighborhoods at Highest Risk for COVID and Better Target Resources to Blunt Local Pandemic Impact

A new city-oriented COVID Local Risk Index will help municipal leaders identify cities and neighborhoods with populations at higher risk of COVID-19 infection and more severe COVID-19 illness by incorporating key risk factors of race and ethnicity, age, household crowding, poverty and underlying health conditions like diabetes and obesity.

Read more

NYU Langone Among First to Enroll Patients In Clinical Trial for COVID-19 Monoclonal Antibody Treatment

The first patients were treated as part of a clinical trial testing whether an antibody therapy can safely reduce COVID-19 disease severity. The experimental treatment consists of identical copies of an antibody, a blood protein related to those that occur naturally as part of the human immune system, researchers say.

Read more

Health System in Pandemic Epicenter Identifies Outcomes and New Risk Factors of Patients Hospitalized with COVID-19

A team of investigators at NYU Langone Health determined that just over half of 5,279 patients who tested positive for COVID-19 were hospitalized — and nearly a quarter of those hospitalized died or were discharged to hospice, including 60 percent who required ventilators.

Read more

Medication Treatments Led to 80 Percent Lower Risk of Fatal Overdose for Patients with Opioid Use Disorder than Medication-free Treatments

Patients with opioid use disorder (OUD) receiving treatment with opioid agonists (medications such as methadone or buprenorphine) had an 80 percent lower risk of dying from an opioid overdose compared to patients in treatment without the use of medications.

Read more

Antianxiety and Antidepressant Effects from a Single Dose of Psychedelic Drug Persist Years Later in Cancer Patients

Following up on their landmark 2016 study, researchers at NYU Grossman School of Medicine found that a one-time, single-dose treatment of psilocybin, a compound found in psychedelic mushrooms, combined with psychotherapy appears to be associated with significant improvements in emotional and existential distress in cancer patients.

Read more

Medicaid Expansion Associated with Fewer Total Opioid Overdose Deaths Across the U.S.

The expansion of Medicaid coverage for low-income adults permitted by the Affordable Care Act (ACA) was associated with a six percent reduction in total opioid overdose deaths nationally, according to new research from NYU Grossman School of Medicine and University of California, Davis.

Read more